Correction to: Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction to: Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study ; day:24 ; month:11 ; year:2023 ; pages:1
Molecular diversity ; (24.11.2023), 1
- Creator
-
Rashmi, S. H.
Disha, K. Sai
Sudheesh, N.
Karunakaran, Kavitha
Joseph, Alex
Jagadesh, Anitha
Mudgal, P. P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11030-023-10748-x
- URN
-
urn:nbn:de:101:1-2024020714480575484938
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rashmi, S. H.
- Disha, K. Sai
- Sudheesh, N.
- Karunakaran, Kavitha
- Joseph, Alex
- Jagadesh, Anitha
- Mudgal, P. P.
- SpringerLink (Online service)
Other Objects (12)
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
Repurposing of approved cardiovascular drugs
Repurposing FDA-approved drugs for anti-aging therapies
Potential for the Repurposing of Adamantane Antivirals for COVID-19
Concurrent infections of dengue virus serotypes in Bali, Indonesia
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Searching for plant-derived antivirals against dengue virus and Zika virus
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
Occurrence of Dengue Virus Infection with Multiple Serotypes at Central Karnataka, India
Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
Repurposing of approved cardiovascular drugs
Repurposing FDA-approved drugs for anti-aging therapies
Potential for the Repurposing of Adamantane Antivirals for COVID-19
Concurrent infections of dengue virus serotypes in Bali, Indonesia
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Searching for plant-derived antivirals against dengue virus and Zika virus
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
Occurrence of Dengue Virus Infection with Multiple Serotypes at Central Karnataka, India
Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
Repurposing of approved cardiovascular drugs
Repurposing FDA-approved drugs for anti-aging therapies
Potential for the Repurposing of Adamantane Antivirals for COVID-19
Concurrent infections of dengue virus serotypes in Bali, Indonesia
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Searching for plant-derived antivirals against dengue virus and Zika virus
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
Occurrence of Dengue Virus Infection with Multiple Serotypes at Central Karnataka, India
Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India